RxSight (RXST) Net Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
RxSight (RXST) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -860.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 124.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 296.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 469.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 92.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -777.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 350.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 67.00 |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -81.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.00 |
| Mar 31, 2026 | -2,980.00 |
| Dec 31, 2025 | -249.00 |
| Sep 30, 2025 | -1,441.00 |
| Jun 30, 2025 | -1,761.00 |
| Mar 31, 2025 | 922.00 |
| Dec 31, 2024 | -399.00 |
| Sep 30, 2024 | 3,798.00 |
| Jun 30, 2024 | 4,891.00 |
| Mar 31, 2024 | 4,471.00 |
| Dec 31, 2023 | 1,352.00 |
| Sep 30, 2023 | 7,739.00 |
| Jun 30, 2023 | 8,096.00 |
| Mar 31, 2023 | 12,123.00 |
| Dec 31, 2022 | 17,687.00 |
| Sep 30, 2022 | 8,571.00 |
| Jun 30, 2022 | 12,792.00 |
| Mar 31, 2022 | -146.00 |
| Dec 31, 2021 | -25,553.00 |
| Sep 30, 2021 | -36,052.00 |